Clinical Utility of Fedratinib in Myelofibrosis

Myelofibrosis (MF) is a clonal hematologic malignancy characterized by bone marrow fibrosis, extramedullary hematopoiesis, splenomegaly, and constitutional symptoms with a propensity towards leukemic transformation. Constitutive activation of the JAK/STAT pathway is a well-described pathogenic featu...

Descripción completa

Detalles Bibliográficos
Autores principales: Waksal, Julian A, Tremblay, Douglas, Mascarenhas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387309/
https://www.ncbi.nlm.nih.gov/pubmed/34456572
http://dx.doi.org/10.2147/OTT.S267001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387309/
https://www.ncbi.nlm.nih.gov/pubmed/34456572
http://dx.doi.org/10.2147/OTT.S267001

Ejemplares similares